Topics

Ovid Therapeutics Reports Q3 Financial Results

12:17 EST 8 Nov 2019 | Investing News Network

Ovid Therapeutics (NASDAQ:OVID) has announced its financial results for Q3 2019 ended September 30. As quoted in the press release: “2020 is poised to be a transformational year for Ovid. We expect multiple clinical trial data readouts across our pipeline including topline results from our pivotal Phase 3 NEPTUNE trial in Angelman syndrome,” said Jeremy … Continued

The post Ovid Therapeutics Reports Q3 Financial Results appeared first on Investing News Network.

Original Article: Ovid Therapeutics Reports Q3 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Ovid Therapeutics Reports Q3 Financial Results"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...